Screener
Axsome Therapeutics AXSM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's invested capital?
- Axsome Therapeutics (AXSM) reported invested capital of -$30.62M in Q1 2026.
- How has Axsome Therapeutics's invested capital changed year-over-year?
- Axsome Therapeutics's invested capital increased by 16.1% year-over-year, from -$36.47M to -$30.62M.
- What is the long-term trend for Axsome Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Axsome Therapeutics's invested capital has grown at a -3.7% compound annual growth rate (CAGR), from -$19.96M to -$16.53M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Axsome Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude